CHRU Tours Hôpital Bretonneau — Tours

Public research footprint of CHRU Tours Hôpital Bretonneau, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cardiac Arrest · Cryptogenic Ischemic Stroke · Oropharyngeal Squamous Cell Carcinoma · Head and Neck Cancer

Recently updated registry entries

NCT07241273 — SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer (Not Yet Recruiting)
NCT07274254 — Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease (Recruiting)
NCT05559398 — Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHRU Tours Hôpital Bretonneau?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.